WARREN KOONTZ: Open Payments
NPI 1023090289 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,794 in 166 payments from 37 companies in 2025. Trend: 2023 $2,059 · 2024 $2,460 · 2025 $2,794
Food & beverage: $2,794
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $343 |
| AstraZeneca Pharmaceuticals LP | 6 | $290 |
| ABBVIE INC. | 27 | $253 |
| Phathom Pharmaceuticals, Inc. | 6 | $198 |
| Amgen Inc. | 21 | $186 |
| Lilly USA, LLC | 11 | $167 |
| Radius Health, Inc. | 5 | $129 |
| GlaxoSmithKline, LLC. | 6 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
Products named: VOQUEZNA, BREZTRI, PREVNAR 20, UBRELVY, Tymlos, OTEZLA, MOUNJARO, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
